What development phase is Feximac in?

Feximac is FDA-approved (marketed).

What is the generic name of Feximac?

BUFEXAMAC is the generic (nonproprietary) name of Feximac.

Last reviewed 2026-04-20 · How we verify

Feximac (BUFEXAMAC)

FDA-approved withdrawn Small molecule Quality 10/100

At a glance

Generic name	BUFEXAMAC
Drug class	bufexamac
Target	Histone deacetylase 10, Histone deacetylase 6, Arachidonate 5-lipoxygenase
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Feximac CI brief — competitive landscape report
Feximac updates RSS · CI watch RSS